scholarly journals A guide to choosing fluorescent protein combinations for flow cytometric analysis based on spectral overlap

2018 ◽  
Vol 93 (5) ◽  
pp. 556-562 ◽  
Author(s):  
Benjamin Kleeman ◽  
Andre Olsson ◽  
Tess Newkold ◽  
Matt Kofron ◽  
Monica DeLay ◽  
...  
2000 ◽  
Vol 182 (11) ◽  
pp. 3289-3291 ◽  
Author(s):  
Lyudmila I. Rachek ◽  
Andria Hines ◽  
Aimee M. Tucker ◽  
Herbert H. Winkler ◽  
David O. Wood

ABSTRACT Rickettsia prowazekii, the etiologic agent of epidemic typhus, is an obligate, intracytoplasmic, parasitic bacterium. Recently, the transformation of this bacterium via electroporation has been reported. However, in these studies identification of transformants was dependent upon either selection of an R. prowazekii rpoB chromosomal mutation imparting rifampin resistance or expression of the green fluorescent protein and flow cytometric analysis. In this paper we describe the expression inR. prowazekii of the Escherichia coli ereBgene. This gene codes for an erythromycin esterase that cleaves erythromycin. To the best of our knowledge, this is the first report of the expression of a nonrickettsial, antibiotic-selectable gene inR. prowazekii. The availability of a positive selection for rickettsial transformants is an important step in the characterization of genetic analysis systems in the rickettsiae.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 792-792
Author(s):  
Connie M Arthur ◽  
Nicole H. Smith ◽  
James C. Zimring ◽  
Jeanne E. Hendrickson ◽  
Sean R. Stowell

Abstract Background During red blood cell (RBC) storage, changes occur that increase the clearance of RBCs following transfusion. RBCs also display unique age related changes that target them for removal in vivo, a process commonly termed RBC senescence. However, whether storage related changes simply reflect acceleration of the normal senescent programs that occur in vivo, or whether all RBCs display equal sensitivity to storage induced alterations that enhance clearance following transfusion remains unknown. As a result, we sought to determine whether enhanced RBC removal following storage simply reflects preferential clearance of older RBCs. Methods B6 mice expressing green fluorescent protein (GFP) under a H-2Kb promoter were injected with N-hydroxysulfosuccinimide biotin followed by evaluation of biotinylated RBCs at weekly time points post transfusion by staining RBCs with strepavidin and flow cytometric analysis. At approximately 1 or 35 days post-biotinylation, blood was harvested into citrate phosphate dextrose adenine (CPDA) and RBCs were immediately transfused or stored in CPDA for 21 days prior to transfusion. Prior to transfusion, the percent of RBCs that remained biotinylated was enumerated. Following transfusion, mice were bleed at 10 minutes, 1 hour or 2 hours followed by daily bleeds for 7 days and weekly thereafter and the ratio of biotin and GFP double positive to GFP single positive RBCs was examined by staining RBCs with strepavidin followed by flow cytometric analysis. Results Immediately after whole mouse biotinylation, nearly 100% of donor RBCs became strepavidin positive. The percent strepavidin positivity gradually decreased until approximately 20% of the total RBCs remained strepavidin positive 35 days post-biotinylation. RBCs harvested 35 days post biotinylation into CPDA and transfused immediately exhibited gradual clearance over time, such that very few transfused RBCs were detectable 40 days post transfusion. In contrast, the percent of transfused RBCs that remained biotin positive rapidly declined to undetectable levels within 7 days following transfusion. Transfused RBCs harvested only 1 day following biotinylation failed to display enhanced clearance during the same 7 day interval. In contrast, the percent of biotin positive RBCs remained unchanged during storage. In addition, transfusion of stored RBCs failed to result in selective clearance of biotin positive RBCs during the initial clearance phase, although biotin positive RBCs appeared to retain enhanced rates of removal following the initial phase of RBC removal. Conclusion Older RBCs appear to retain signals that result in preferential removal compared to younger RBCs following harvesting, processing and transfusion into a new recipient. Preferential clearance of older RBCs does not appear to reflect a biotinylation artifact, as newly biotinylated RBCs failed to display similar increases in RBC clearance. However, storage induced changes do not appear to result in selective removal of older RBCs, as biotinylated and non-biotinylated RBCs displayed significant removal during the initial phase of clearance following transfusion. Taken together, these results suggest that older RBCs retain senescent markers that results in enhanced clearance, but that RBC storage induces unique RBC changes that marks them for rapid clearance largely independent of RBC age. Disclosures: Zimring: Immucor Inc.: Research Funding; Terumo: Research Funding; Haemonetics: Consultancy; Cerus: Honoraria.


2020 ◽  
Vol 20 (7) ◽  
pp. 790-799 ◽  
Author(s):  
Farnaz D. Moghaddam ◽  
Pejman Mortazavi ◽  
Somayeh Hamedi ◽  
Mohammad Nabiuni ◽  
Nasim H. Roodbari

Background and Purpose: Melittin, as the main ingredient of honeybee venom, that has shown anticancer properties. The present study aimed at investigating the cytotoxic impacts of melittin on 4T1 breast cancer cells. Methods: Hemolytic activity of different concentrations (0.125, 0.25, 0.5, 1, 2, 4, 8μg/ml) of melittin was assayed and then cytotoxicity of selected concentrations of melittin (2, 4, 8, 16, 32, and 64μg/ml), 2 and 4μg/ml of cisplatin and 0.513, 0.295 and 0.123μg/ml of doxorubicin was evaluated on 4T1 cells using MTT assay. We used Morphological evaluation and flow cytometric analysis was used. Real time PCR was also used to determine mRNA expression of Mfn1 and Drp1 genes. Results: All compounds showed anti-proliferative effects on the tumor cell line with different potencies. Melittin had higher cytotoxicity against 4T1 breast cancer cells (IC50= 32μg/ml-72h) and higher hemolytic activity (HD50= 1μg/ml), as compared to cisplatin and doxorubicin. Mellitin at 16 and 32μg/ml showed apoptotic effects on 4T1 cells according to the flow cytometric analysis. The Real time PCR analysis of Drp1 and Mfn1 expression in cells treated with 16μg/ml of melittin revealed an up-regulation in Drp1 and Mfn1 genes mRNA expression in comparison with control group. Treatment with 32μg/ml of melittin was also associated with a rise in mRNA expression of Drp1 and Mfn1 as compared to the control group. Conclusion: The results of this study showed that melittin has anticancer effects on 4T1 cell lines in a dose and time dependent manner and can be a good candidate for further research on breast cancer treatment.


Sign in / Sign up

Export Citation Format

Share Document